Krystal Biotech (KRYS) Financials

$315.82

up-down-arrow $0.48 (0.15%)

As on 19-Nov-2026 16:00EST

Market cap

info icon

$9,045 Mln

Revenue (TTM)

info icon

$470 Mln

P/E Ratio

info icon

41.5

P/B Ratio

info icon

6.3

Div. Yield

info icon

0 %

Income Statement ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Operating Revenue
470.03
389.13
290.52
50.70
--
--
Cost of Revenue
31.23
28.77
20.06
3.09
4.06
2.77
Gross Profit
438.79
360.36
270.45
47.61
-4.06
-2.77
Operating Expenses
211.10
199.06
204.76
157.33
145.20
68.28
Operating Profit (EBIT)
227.69
161.30
65.70
-109.73
-145.20
-68.28
Other Income
--
--
--
--
--
--
Profit before Tax
258.80
189.47
95.36
12.90
-139.98
-69.57
Provision for Tax
33.63
-15.36
6.20
1.97
34.05
2.73
Profit after Tax (Net Income)
225.17
204.83
89.16
10.93
-139.98
-69.57
Minority Interest
--
--
--
--
--
--
Consolidated Profit
--
--
--
--
-139.98
-69.57

Liabilities ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Shareholder's Funds
1,435.58
1,219.56
946.38
778.64
522.23
593.58
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
8.33
11.29
7.46
6.62
7.37
6.98
Current Liabilities
142.14
102.94
102.00
33.09
28.85
25.74
Total Liabilities
1,728.20
1,333.79
1,055.84
818.36
558.45
626.30

Assets ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Non-Current Assets
464.29
309.19
313.79
230.45
174.67
184.03
Current Assets
1,121.76
1,024.60
742.05
587.91
383.78
442.27
Total Assets
1,728.20
1,333.79
1,055.84
818.36
558.45
626.30
Total Debt*
8.59
9.34
7.26
8.09
8.93
8.02
Net Current Assets
979.62
921.66
640.05
554.82
354.93
416.53

Cashflow ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Cash From Operating Activities
--
200.87
123.42
-88.80
-100.57
-47.94
Cash Flow from Investing Activities
--
-58.42
-163.44
82.64
-114.08
-226.77
Cash from Financing Activities
--
8.71
27.01
202.75
35.35
347.69
Net Cash Inflow / Outflow
--
--
--
--
--
72.98

Financials Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Adjusted EPS ($) info
7.38
6.84
2.98
0.38
-5.48
-3.13
Cash EPS ($) info
--
7.06
3.21
0.55
-5.32
-3.01
Adjusted Book Value ($) info
--
40.72
31.67
27.02
20.44
26.73
Dividend per Share ($) info
--
--
--
--
--
--
Cash Flow per Share ($) info
--
6.71
4.13
-3.08
-3.94
-2.16
Free Cash Flow per Share ($) info
--
6.31
3.99
-3.49
-6.01
-5.24

Profitability Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
ROCE (%) info
--
18.77
10.25
1.66
-24.71
-15.37
ROE (%) info
16.60
18.91
10.34
1.68
-25.09
-15.71
ROA (%) info
14.72
17.14
9.51
1.59
-23.63
-14.85
EBIT Margin (%) info
52.23
48.69
35.52
-191.77
--
--
Net Margin (%) info
47.91
52.64
30.69
21.56
--
--
Cash Profit Margin (%) info
0.00
--
--
--
--
--

Growth Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Revenue Growth (%) info
25.96
0.34
4.73
--
--
--
EBIT Growth (%) info
31.32
83.60
206.14
19.11
-76.56
-111.64
Net Profit Growth (%) info
13.20
129.74
715.58
107.81
-101.20
-116.28
EPS Growth (%) info
10.71
1.29
6.87
1.07
-0.75
-0.95
Book Value Growth (%) info
22.05
--
--
--
--
--

Valuation Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Price / Earnings info
41.47
36.05
52.51
327.03
-14.46
-22.33
Price / Book Value info
6.31
6.05
4.95
4.59
3.88
2.62
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
34.82
33.49
37.22
-33.08
-14.24
-17.20
Close Price ($) info
332.56
246.54
156.66
124.06
79.22
69.95
High Price ($) info
382.54
265.92
219.34
132.68
85.11
102.99
Low Price ($) info
175.85
122.80
107.50
69.81
47.67
38.86
Market Cap ($ Cr) info
9,045.02
--
--
--
--
--

Solvency Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Debt to Equity info
--
0.01
0.01
0.01
0.02
0.01
Short term debt to equity ratio info
0.00
0.00
0.00
0.00
0.00
0.00
Current Ratio info
7.89
9.95
7.28
17.76
13.30
17.18
Quick Ratio info
7.53
9.56
7.02
17.55
13.30
--
Interest Coverage info
--
--
--
--
-23.02
-45.63

Operating Efficiency Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Debtors to sales (%) info
28.32
32.75
36.06
82.92
--
--
Asset Turnover info
0.31
0.33
0.31
0.07
--
--
Receivable days info
--
108.96
92.27
151.43
--
--
Inventory Days info
--
425.15
304.90
412.29
--
--
Payable days info
--
52.19
62.21
344.12
557.51
692.71
Cash Conversion Cycle info
--
481.92
334.96
219.61
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month